US 9994856
Method for increasing the activity of a cystic fibrosis transmembrane conductance regulator protein
granted A61KA61K31/7088A61K31/712
Quick answer
US patent 9994856 (Method for increasing the activity of a cystic fibrosis transmembrane conductance regulator protein) held by ProQR Therapeutics II B.V. expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ProQR Therapeutics II B.V.
- Grant date
- Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/7088, A61K31/712, A61K38/465, A61K45/06